The association between malignant melanoma and noncutaneous malignancies

International Journal of Dermatology

Volumn 45, Issue 5, 2006, Pages 529-534

  Wu, Yu Hung ^a,b,c   Kim, Gene H ^a,b,c   Wagner, Jeffrey D ^a,b,c   Hood, Antoinette F ^a,b,c   Chuang, Tsu Yi ^a,b,c,d  

^a MACKAY MEMORIAL HOSPITAL   (Taiwan)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER CLASSIFICATION; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIGESTIVE SYSTEM CANCER; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; FEMALE; HIGH RISK POPULATION; HUMAN; KIDNEY CARCINOMA; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEUROENDOCRINE TUMOR; NONHODGKIN LYMPHOMA; POPULATION DISTRIBUTION; PREVALENCE; PROSTATE CANCER; RISK ASSESSMENT; SEX RATIO; SOLID TUMOR; STANDARDIZATION; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

CARCINOMA, RENAL CELL; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; INDIANA; KIDNEY NEOPLASMS; LYMPHOMA, NON-HODGKIN; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; SKIN DISEASES; SKIN NEOPLASMS;

EID: 33646237575     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2005.02640.x     Document Type: Article

References (43)

1. Fraser DG, Bull JG, Dunphy JE. Malignant melanoma and coexisting malignant neoplasms. Am J Surg 1971; 122: 169-174.
2. Boland SL, Shaw HM, Milton GW. Multiple primary cancers in patients with malignant melanoma. Med J Aust 1976; 1: 517-519.
3. Bellet RE, Vaisman I, Mastrangelo MJ, et al. Multiple primary malignancies in patients with cutaneous melanoma. Cancer 1977; 40: 1974-1981.
4. Turner BJ, Siatkowski RM, Augsburger JJ, et al. Other cancers in uveal melanoma patients and their families. Am J Ophthalmol 1989; 107: 601-608.
5. Gutman M, Avital C, Moshe I, et al. Are malignant melanoma patients at higher risk for a second cancer? Cancer 1991; 68: 660-665.
6. Schallreuter KU, Levenig C, Berger J. Cutaneous malignant melanoma with other coexisting neoplasm: A true association? Dermatology 1993; 186: 12-17.
7. Swerdlow AJ, Storm HH, Sasieni PD, et al. Risks of second primary malignancy in patients with cutaneous and ocular melanoma in Denmark, 1943-1989. Int J Cancer 1995; 61: 773 -779.
8. Wassberg C, Thorn M, Yuen J, et al. Second primary cancers in patients with cutaneous malignant melanoma: A population-based study in Sweden. Br J Cancer 1996; 73: 255-259.
9. Levi F, Vecchia CL, Randimbison L, et al. Incidence of invasive cancers following cutaneous malignant melanoma. Int J Cancer 1997; 72: 776-779.
10. Bhatia S, Estrada-Batres L, Maryon T, et al. Second primary tumors in patients with cutaneous malignant melanoma. Cancer 1999; 86: 2014-2020.
11. Green AC, O'Rourke MGE. Cutaneous malignant melanoma in association with other skin cancers. J Natl Cancer Inst 1985; 74: 977-980.
12. DiFronzo LA, Wanek LA, Elashoff R, et al. Increased incidence of second primary melanoma in patients with a previous cutaneous melanoma. Ann Surg Oncol 1999; 6: 705-711.
13. Travis LB, Curtis RE, Boice JD, et al. Second cancers following non-Hodgkin's lymphoma. Cancer 1991; 67: 2002-2009.
14. Goggins WB, Finkelstein DM, Tsao H. Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma. Cancer 2001; 91: 874-880.
15. Travis LB, Curtis RE, Glimelius B, et al. Second cancers among long-term survivors of non-Hodgkin's lymphoma. J Natl Cancer Inst 1993; 85: 1932-1937.
16. Hall P, Rosendahl I, Mattsson A, et al. Non-Hodgkin's lymphoma and skin malignancies -shared etiology? Int J Cancer 1995; 62: 519-522.
17. Tucker MA, Misfeldt D, Coleman CN, et al. Cutaneous malignant melanoma after Hodgkin's disease. Ann Intern Med 1985; 102: 37-41.
18. van Leeuwen FE, Klokman WJ, Hagenbeek A, et al. Second cancer risk following Hodgkin's disease: A 20-year follow-up study. J Clin Oncol 1994; 12: 312-325.
19. Schenk M, Severson RK, Pawlish KS. The risk of subsequent primary carcinoma of the pancreas in patients with cutaneous malignant melanoma. Cancer 1998; 82: 672-676.
20. Dong C, Hemminki K. Multiple primary cancers of the colon, breast and skin (melanoma) as models for polygenic cancers. Int J Cancer 2001; 92: 883-887.
21. Chua HC, Mortimer PS. Malignant melanoma occurring as a second cancer following primary germ cell tumour in males: Report of three cases. Br J Dermatol 1992; 127: 448-449.
22. Travis LB, Curtis RE, Storm H, et al. Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst 1997; 89: 1429-1439.
23. Bailar JC, Ederer F. Significance factors for the ratio of a Poisson variable to its expectation. Biometrics 1964; 20: 639-642.
24. Rhodes AR, Weinstock MA, Fitzpatrick TB, et al. Risk factors for cutaneous melanoma. J Am Med Assoc 1987; 258: 3146-3154.
25. Koh HK, Sinks TH, Geller AC, et al. Etiology of melanoma. Cancer Treat Res 1993; 65: 1-28.
26. Mackie RM, Freudenberger T, Aitchison TC. Multiple personal risk-factor chart for cutaneous melanoma. Lancet 1989; 2: 487-490.
27. Greene MH. The genetics of hereditary melanoma and nevi. 1998 update. Cancer 1999; 86 (11 Suppl.): 2464-2477.
28. Borg A, Sandberg T, Nilsson K, et al. High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families. J Natl Cancer Inst 2000; 92: 1260-1266.
29. Vasen HF, Gruis NA, Frants RR, et al. Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden). Int J Cancer 2000; 87: 809-811.
30. Azizi E, Friedman J, Pavlotsky F, et al. Familial cutaneous malignant melanoma and tumors of the nervous system. A hereditary cancer syndrome. Cancer 1995; 76: 1571-1578.
31. Licata AG, Wilson LD, Braverman IM. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation. Arch Dermatol 1995; 131: 432-435.
32. Riou JP, Ariyan S, Brandow KR, Fielding LP. The association between melanoma, lymphoma, and other primary neoplasms. Arch Surg 1995; 130: 1056-1061.
33. Adami J, Gridley G, Nyren O, et al. Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden. Int J Cancer 1999; 80: 641-645.
34. McKenna DB, Doherty VR, McLaren KM, et al. Malignant melanoma and lymphoproliferative malignancy: Is there a shared aetiology? Br J Dermatol 2000; 143: 171-173.
35. Adami J, Frisch M, Yuen J, et al. Evidence of an association between non-Hodgkin's lymphoma and skin cancer. Br Med J 1995; 310: 1491-1495.
36. Brennan P, Coates M, Armstrong B, et al. Second primary neoplasms following non-Hodgkin's lymphoma in New South Wales, Australia. Br J Cancer 2000; 82: 1344-1347.
37. McKenna DB, Stockton D, Brewster DH, et al. Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: A population-based retrospective cohort study in Scotland. Br J Cancer 2003; 88: 74-78.
38. Tsao H, Kwitkiwski K, Sober AJ. A single-institution case series of patients with cutaneous melanoma and non-Hodgkin's lymphoma. J Am Acad Dermatol 2002; 46: 55-61.
39. Tihan T, Filippa DA. Coexistence of renal cell carcinoma and malignant lymphoma. A causal relationship or coincidental occurrence? Cancer 1996; 77: 2325-2331.
40. Schmid-Wendtner MH, Baumert J, Wendtner CM, et al. Risk of second primary malignancies in patients with cutaneous melanoma. Br J Dermatol 2001; 145: 981-985.
41. Vanhaelen PJ, Fisher RI. Increased sensitivity of T cells to regulation by normal suppressor cells persists in long-term survivors with Hodgkin's disease. Am J Med 1982; 72: 385-390.
42. Kobayashi H, Tanaka Y, Yagi J, et al. Gamma/delta T cells provide innate immunity against renal cell carcinoma. Cancer Immunol Immunother 2001; 50: 115-124.
43. Rosenberg SA. Interleukin-2 and the development of immunotherapy for the treatment of patients with cancer. Cancer J Sci Am 2000; 6 (Suppl.): S2-S7.